Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective lowered by Truist Financial from $86.00 to $70.00 in a research report released on Wednesday morning, Benzinga reports. Truist Financial currently has a buy rating on the biopharmaceutical company’s stock. Several other research firms have also recently weighed in on CYTK. JMP Securities cut their price […]
StockNews.com cut shares of MSC Industrial Direct (NYSE:MSM – Free Report) from a buy rating to a hold rating in a report released on Wednesday morning. Other equities analysts also recently issued research reports about the company. Robert W. Baird downgraded MSC Industrial Direct from an outperform rating to a neutral rating and dropped their […]
Baird R W lowered shares of MSC Industrial Direct (NYSE:MSM – Free Report) from a strong-buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. A number of other equities analysts also recently issued reports on MSM. Robert W. Baird downgraded MSC Industrial Direct from an outperform rating to a […]
Employers Holdings, Inc. (NYSE:EIG – Get Free Report) insider Ann Marie Smith sold 1,764 shares of the company’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $41.26, for a total value of $72,782.64. Following the completion of the transaction, the insider now directly owns 6,741 shares […]
Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) CEO Andrew Hykes sold 3,000 shares of Inari Medical stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $50.00, for a total transaction of $150,000.00. Following the completion of the transaction, the chief executive officer now directly owns 465,474 […]